Infliximab-induced vitiligo.
Ramírez-Hernández
Mercedes
M
Marras
Carlos
C
Martínez-Escribano
Jorge A
JA
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003937:Diagnosis, Differential; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D014820:Vitiligo / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab